Pomanda estimates the enterprise value of ADVANCE PHARMA LTD at £677k based on a Turnover of £1.8m and 0.37x industry multiple (adjusted for size and gross margin).
advance pharma ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of ADVANCE PHARMA LTD at £0 based on an EBITDA of £-99.3k and a 3.47x industry multiple (adjusted for size and gross margin).
advance pharma ltdEstimated Valuation
£114.2k
Pomanda estimates the enterprise value of ADVANCE PHARMA LTD at £114.2k based on Net Assets of £51.5k and 2.22x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advance Pharma LtdOverview
Advance Pharma Ltd is a live company located in walsall, WS2 9HY with a Companies House number of 07893857. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in December 2011, it's largest shareholder is
shaheen kauser
with a 37% stake. Advance Pharma Ltd is a established,
small sized company, Pomanda has estimated its turnover at
£1.8m with
high
growth in recent years.
Pomanda's financial health check has awarded Advance Pharma Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
2 Strong
2 Regular
6 Weak
Size
annual sales of £1.8m, make it smaller than the average company (£6.5m)
£1.8m - Advance Pharma Ltd
£6.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a faster rate (6.4%)
16% - Advance Pharma Ltd
6.4% - Industry AVG
Production
with a gross margin of 24.2%, this company has a higher cost of product (35.7%)
24.2% - Advance Pharma Ltd
35.7% - Industry AVG
Profitability
an operating margin of -5.5% make it less profitable than the average company (4.3%)
-5.5% - Advance Pharma Ltd
4.3% - Industry AVG
Employees
with 19 employees, this is below the industry average (45)
19 - Advance Pharma Ltd
45 - Industry AVG
Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)
£25.8k - Advance Pharma Ltd
£25.8k - Industry AVG
Efficiency
resulting in sales per employee of £95.8k, this is equally as efficient (£97.5k)
£95.8k - Advance Pharma Ltd
£97.5k - Industry AVG
Debtor Days
it gets paid by customers after 64 days, this is later than average (26 days)
64 days - Advance Pharma Ltd
26 days - Industry AVG
Creditor Days
its suppliers are paid after 80 days, this is slower than average (40 days)
80 days - Advance Pharma Ltd
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Advance Pharma Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Advance Pharma Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.4%, this is a higher level of debt than the average (42.5%)
94.4% - Advance Pharma Ltd
42.5% - Industry AVG
ADVANCE PHARMA LTD financials
EXPORT
Advance Pharma Ltd's latest turnover from August 2023 is estimated at £1.8 million and the company has net assets of £51.5 thousand. According to their latest financial statements, Advance Pharma Ltd has 19 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Aug 2023
Aug 2022
Aug 2021
Aug 2020
Aug 2019
Aug 2018
Aug 2017
Aug 2016
Aug 2015
Aug 2014
Aug 2013
Aug 2012
Turnover
1,819,492
1,649,358
1,366,730
1,172,943
979,184
1,040,576
579,162
473,519
700,262
405,408
Other Income Or Grants
Cost Of Sales
1,379,270
1,236,798
1,041,605
900,934
745,698
785,271
427,744
351,183
530,413
301,779
Gross Profit
440,221
412,561
325,125
272,009
233,486
255,305
151,418
122,336
169,849
103,628
Admin Expenses
539,525
385,804
289,557
273,541
198,821
220,731
128,579
91,931
165,393
104,540
Operating Profit
-99,304
26,757
35,568
-1,532
34,665
34,574
22,839
30,405
4,456
-912
Interest Payable
Interest Receivable
55
31
33
123
83
Pre-Tax Profit
-99,304
26,757
35,568
-1,532
34,665
34,628
22,870
30,438
4,579
-829
Tax
-5,084
-6,758
-6,586
-6,579
-4,345
-6,087
-916
Profit After Tax
-99,304
21,673
28,810
-1,532
28,079
28,049
18,525
24,350
3,663
-829
Dividends Paid
Retained Profit
-99,304
21,673
28,810
-1,532
28,079
28,049
18,525
24,350
3,663
-829
Employee Costs
490,680
533,972
391,564
308,536
306,586
294,071
303,227
96,409
156,286
97,844
Number Of Employees
19
22
17
14
14
14
15
5
8
5
EBITDA*
-99,304
26,757
35,568
-1,532
34,665
34,574
23,914
31,554
5,892
133
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2023
Aug 2022
Aug 2021
Aug 2020
Aug 2019
Aug 2018
Aug 2017
Aug 2016
Aug 2015
Aug 2014
Aug 2013
Aug 2012
Tangible Assets
602,165
1,410
1,762
2,202
2,752
3,439
4,299
4,594
5,743
4,179
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
602,165
1,410
1,762
2,202
2,752
3,439
4,299
4,594
5,743
4,179
Stock & work in progress
22,805
28,795
32,667
19,891
Trade Debtors
321,854
314,290
286,518
252,762
205,719
217,875
110,686
117,854
154,103
81,279
Group Debtors
Misc Debtors
15,969
6,368
Cash
14,598
10,342
15,897
33,119
misc current assets
total current assets
321,854
314,290
286,518
252,762
205,719
217,875
164,058
163,359
202,667
134,289
total assets
924,019
315,700
288,280
254,964
208,471
221,314
168,357
167,953
208,410
138,468
Bank overdraft
Bank loan
Trade Creditors
303,535
164,912
159,165
154,659
89,634
110,556
54,345
43,955
115,476
79,197
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
31,203
36,714
total current liabilities
303,535
164,912
159,165
154,659
89,634
110,556
85,548
80,669
115,476
79,197
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
569,000
17,000
37,000
37,000
60,000
90,000
60,000
provisions
total long term liabilities
569,000
17,000
37,000
37,000
60,000
90,000
60,000
total liabilities
872,535
164,912
159,165
154,659
106,634
147,556
122,548
140,669
205,476
139,197
net assets
51,484
150,788
129,115
100,305
101,837
73,758
45,809
27,284
2,934
-729
total shareholders funds
51,484
150,788
129,115
100,305
101,837
73,758
45,809
27,284
2,934
-729
Aug 2023
Aug 2022
Aug 2021
Aug 2020
Aug 2019
Aug 2018
Aug 2017
Aug 2016
Aug 2015
Aug 2014
Aug 2013
Aug 2012
Operating Activities
Operating Profit
-99,304
26,757
35,568
-1,532
34,665
34,574
22,839
30,405
4,456
-912
Depreciation
1,075
1,149
1,436
1,045
Amortisation
Tax
-5,084
-6,758
-6,586
-6,579
-4,345
-6,087
-916
Stock
-22,805
-5,990
-3,872
12,776
19,891
Debtors
7,564
27,772
33,756
47,043
-12,156
91,220
2,433
-29,881
72,824
81,279
Creditors
138,623
5,747
4,506
65,025
-20,922
56,211
10,390
-71,521
36,279
79,197
Accruals and Deferred Income
-31,203
-5,511
36,714
Deferred Taxes & Provisions
Cash flow from operations
31,755
-352
-440
16,450
19,313
-15,412
28,005
24,413
-44,345
-21,840
Investing Activities
capital expenditure
-600,755
352
440
550
687
860
-780
-3,000
-5,224
Change in Investments
cash flow from investments
-600,755
352
440
550
687
860
-780
-3,000
-5,224
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
569,000
-17,000
-20,000
-23,000
-30,000
30,000
60,000
share issue
-100
100
interest
55
31
33
123
83
cash flow from financing
569,000
-17,000
-20,000
-45
-22,969
-29,967
30,123
60,183
cash and cash equivalents
cash
-14,598
4,256
-5,555
-17,222
33,119
overdraft
change in cash
-14,598
4,256
-5,555
-17,222
33,119
advance pharma ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for advance pharma ltd. Get real-time insights into advance pharma ltd's credit score, group structure and payment trends.
Perform a competitor analysis for advance pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in WS2 area or any other competitors across 12 key performance metrics.
advance pharma ltd Ownership
ADVANCE PHARMA LTD group structure
Advance Pharma Ltd has no subsidiary companies.
Ultimate parent company
ADVANCE PHARMA LTD
07893857
ADVANCE PHARMA LTD Shareholders
The largest shareholders in Advance Pharma Ltd include Shaheen Kauser and Bilal Arshad Shah.
shaheen kauser
37%
bilal arshad shah
33%
taseen iqbal
30%
advance pharma ltd directors
Advance Pharma Ltd currently has 3 directors.
The longest serving directors include
Mrs Shaheen Kauser (Dec 2011) and
Mr Taseen Iqbal (Dec 2011).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to advance pharma ltd. Currently there are 2 open charges and 0 have been satisfied in the past.
advance pharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANCE PHARMA LTD. This can take several minutes, an email will notify you when this has completed.
advance pharma ltdCompanies House Filings - See Documents
